Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

164 trials

NCT07150000
Recruiting
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Not applicable · Germany · 1 site
Registry update: 2 Sept 2025
NCT06672822
Recruiting
Intralesional Injection of STS in Treatment of Calcinosis
Phase 2 · United States · 1 site
Registry update: 5 May 2026
NCT06865118
Recruiting
Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis
Not applicable · Norway · 1 site
Registry update: 19 Mar 2025
NCT06801119
Recruiting
Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）
Phase 1 · China · 1 site
Registry update: 12 Aug 2026
NCT06925542
Recruiting
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Phase 1 · Germany, Spain, United States · 17 sites
Registry update: 26 Oct 2026
NCT06827977
Recruiting
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
Phase 2 · United States · 1 site
Registry update: 8 Jul 2026
NCT06822881
Recruiting
CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
Phase 1 · China · 1 site
Registry update: 10 Mar 2026
NCT06941129
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 29 Sept 2025
NCT06954597
Recruiting
Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Phase 2 · Switzerland, France · 6 sites
Registry update: 1 Oct 2026
2023-510507-21-00
Recruiting
EvER-ILD 3 : Evaluation of Efficacy and safety of Rituximab and mycophenolate mofetil combination in patients with Interstitial Lung Disease related to systemic sclerosis: a multicentre double-blind placebo-controlled randomized trial.
Phase 2/3 · France · 24 sites
Registry update: 1 Oct 2024
2023-505977-34-00
Recruiting
Phase I/II randomized clinical trial of allogeneic adipose tissue-derived mesenchymal stromal cells systemic infusion in severe systemic sclerosis MSC-AT-SSc
Phase 2 · France · 3 sites
Registry update: 3 Apr 2026
NCT06549231
Recruiting
Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis
Phase 3 · France · 1 site
Registry update: 12 Jun 2026
NCT06614270
Recruiting
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
Not applicable · China · 1 site
Registry update: 29 Dec 2025
NCT06675344
Recruiting
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Not applicable · United States · 4 sites
Registry update: 8 Jan 2026
NCT06375005
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
Phase 2 · China · 9 sites
Registry update: 11 Feb 2025
NCT06775912
Recruiting
Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 2 Feb 2026
NCT06794008
Recruiting
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Phase 2 · China · 1 site
Registry update: 2 Apr 2025
2023-506230-71-01
Recruiting
Vaccination in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on the immunogenicity of herpes-zoster vaccine (Shingrix) and protection against infection (HZ-REUMA)
Phase 4 · Sweden · 1 site
Registry update: 6 Nov 2023
NCT06732674
Recruiting
Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
Not applicable · Norway · 1 site
Registry update: 19 Dec 2024
NCT06716606
Recruiting
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Phase 3 · Argentina, Australia, China, Spain, France, United Kingdom, Greece, Israel, Japan, South Korea, United States · 35 sites
Registry update: 9 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.